Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / April / Maternal Diabetes and the Hidden Risk of ROP
Pediatric Retina News

Maternal Diabetes and the Hidden Risk of ROP

Retrospective cohort study links maternal diabetes to increased ROP risk in premature infants

4/7/2026 2 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Top Institutions
Objective:

To investigate the association between maternal diabetes and the risk of severe retinopathy of prematurity (ROP) in premature infants.

Key Findings:
  • 10% of infants developed Stage 3–5 ROP, a vision-threatening condition.
  • Maternal diabetes was present in approximately 9% of pregnancies.
  • Infants exposed to maternal diabetes had nearly three times the odds of developing severe ROP.
  • Type 1 and Type 2 diabetes significantly increased the odds of severe ROP by over sixfold.
  • Gestational diabetes showed a weaker, non-significant association with severe ROP.
Interpretation:

Maternal diabetes may be an under-recognized risk factor for ROP progression, suggesting a need for revised screening strategies that include maternal metabolic history.

Limitations:
  • The study does not establish causality between maternal diabetes and ROP.
  • Findings may not be generalizable beyond the studied population.
Conclusion:

Incorporating maternal diabetes exposure into ROP screening decisions could enhance early identification of at-risk infants, especially as survival rates for extremely premature infants improve.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: